Chinese herbal medicine for bone health

Pharmaceutical Biology

Volumn 52, Issue 9, 2014, Pages 1223-1228

  Mukwaya, Emmanuel ^a   Xu, Fei ^a   Wong, Man Sau ^b,c   Zhang, Yan ^a,b,c  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^b State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Fracture; Herbal formula; Inflammation; Osteoblast; Osteoclast; Osteoporosis

Indexed keywords

ANEMARRHENA EXTRACT; ANGELICA SINENSIS EXTRACT; ASTRAGALUS EXTRACT; BU ZHONG YI QI TANG; CURCULIGINIS EXTRACT; DIPSACI ASPEROIDIS EXTRACT; DRYNARIAE EXTRACT; ECLIPTA EXTRACT; EPIMEDIUM EXTRACT; ER XIAN; ER ZHI WAN; ERYTHRINA EXTRACT; EUCOMMIA EXTRACT; EUCOMMIA ULMOIDES EXTRACT; LIGUSTRUM LUCIDUM EXTRACT; MORINDA OFFICINALIS EXTRACT; PHELLODENDRON EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PSORALEA EXTRACT; REHMANNIA EXTRACT; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG; XIAN LING GU BAO; HERBACEOUS AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BONE DENSITY; BONE STRENGTH; CARTHAMUS; CHEMICAL COMPOSITION; CHINESE MEDICINE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EPIMEDIUM; EUCOMMIACEAE; FRACTURE; FRACTURE HEALING; GARDENIA; HERBAL MEDICINE; HUMAN; LIGUSTRUM; MUSCULOSKELETAL SYSTEM INFLAMMATION; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PANAX NOTOGINSENG; PHARMACOLOGY; PRESCRIPTION; REVIEW; RHUBARB; SAMBUCUS; STANDARDIZATION; SYSTEMATIC REVIEW; TOXICITY TESTING; ADVERSE EFFECTS; ANIMAL; BONE DISEASES; CHEMISTRY; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; BONE DISEASES; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; TOXICITY TESTS;

EID: 84906060748     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.884606     Document Type: Review

References (78)

1. Andreassen H, Rungby J, Dahlerup JF. (1997). Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 32:1247-55.
2. Armour KE, Van'T Hof RJ, Grabowski P, et al. (1999). Evidence for a pathogenic role of nitric oxide in inflammation induced osteoporosis. J Bone Min Res 14:2137-42.
3. Beral V, Million Women Study Collaborators. (2003). Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419-27.
4. Bian Q, Liu SF, Huang JH, et al. (2012). Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro. Menopause 19:225-33.
5. Chan K. (1995). Progress in traditional Chinese medicine. Trends Pharmacol Sci 16:182-7.
6. Cheng M, Wang Q, Fan Y, et al. (2011). A traditional Chinese herbal preparation, Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats. J Ethnopharmacol 138:279-85.
7. Dannenberg AM, Schofield BH, Rao JB. (1994). Histochemical demonstration of hydrogen peroxide production by leukocytes in fixed-frozen tissue sections of inflammatory lesions. J Leukoc Biol 56:436-43.
8. Deodhar AA, Woolf AD. (1996). Bone mass measurement and bone metabolism in rheumatoid arthritis: A review. Br J Rheumatol 35: 309-22.
9. Dong TT, Zhao KJ, Gao QT, et al. (2006). Chemical and biological assessment of a Chinese herbal decoction containing Radix Astragali and Radix Angelicae sinensis: Determination of drug ratio in having optimized properties. J Agric Food Chem 54:2767-74.
10. Drayton DL, Liao S, Mounzer RH, Ruddle NH. (2006). Lymphoid organ development: From ontogeny to neogenesis. Nat Immunol 7: 344-53.
11. Frost A, Jonsson KB, Ridefelt P. (1999). Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via a mechanism not dependent on endogenous prostaglandin formation. Acta Orthop 70:497-503.
12. Gao QT, Cheung JK, Li J, et al. (2007). A Chinese herbal decoction, Danggui Buxue Tang, activates extracellular signal-regulated kinase in cultured T-lymphocytes. FEBS Lett 581:5087-93.
13. Gao Z, Huang K, Yang X, Xu H. (1999). Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1472:643-50.
14. Genant HK, Delmas PD, Chen P, et al. (2007). Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18:69-76.
15. Ha H, Ho J, Shin S, et al. (2003). Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch Phama Res 26:929-36.
16. Han LM, Liu B, Xu P. (2003). Influence of Herba epimedii flavone on proliferation of osteoblast. Shanghai J Tradit Chin Med 37:56-8.
17. Heck DE, Laskin DL, Gardner CR. (1992). Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267:21277-80.
18. Hidaka S, Okamoto Y, Miyazaki K, Uesugi T. (2003). Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother Res 17:112-19.
19. Hong YL, Pan HZ, Scott MD, Meshnick SR. (1992). Activated oxygen generation by a primaquine metabolite: Inhibition by antioxidants derived from Chinese herbal remedies. Free Radic Biol Med 12: 213-18.
20. Hsiao JIH. (2007). Patent protection for Chinese herbal medicine product invention in Taiwan. J World Intell Prop 10:1-21.
21. Huang SQ, Wang B, Wang J, et al. (2005). Experiment on antiatherosis effect of daguibuxue decoction in rabbits. Beijing Zhong Yi Yao DaXue Xue Bao 28:140-4.
22. Huang W, Yang YF. (2003). Pharmacological and clinical research progression of Privet Berry and its active ingredient. Modern J Integ Trad Chin Wester Med 12:772-4.
23. Jeong JC, Kang SK, Yoon CH, et al. (2005). Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Int Immunopharmacol 96:489-95.
24. Jeong JC, Kang SK, Yoon CH, et al. (2003). Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3: 1685-97.
25. Jiang YN, Mo HY, Chen JM. (2012). Effects of Epimedium total flavonoids phytosomes on preventing and treating bone loss of ovariectomized rats. China J Chin Mater Med 27:221-4.
26. Kawashima K, Nomura A, Makino T, et al. (2004). Pharmacological properties of traditional medicine (XXIX): Effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. Biol Pharm Bull 27:1599-603.
27. Krempien B, Vukicevic S, Vogel M. (1988). Cellular basis of inflammation-induced osteopenia in growing rats. J Bone Min Res 3:573-82.
28. Lacey Jr JV, Mink PJ, Lubin JH, et al. (2002). Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-41.
29. Landry PS, Marino AA, Sadasivan K. (2000). Effect of soft tissue trauma on the early periosteal response of bone to injury. J Trauma 48: 479-83.
30. Lee GH. (2002). Inhibition of Drynariae Rhizoma extracts on bone resorption in mice. Ph.D. [thesis]. Kyungju, Korea: Dongguk University Graduate School.
31. Lee YB, Lee HJ, Kim KS, et al. (2004). Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotech Biochem 68:1040-5.
32. Li Y, Ji H, Li P, Xie L. (2002). Effects of Epimedium pubescens flavonoids on osteoblast in vitro. J Chin Pharm Univ 33: 48-50.
33. Liu HC, Chen RM, Jian WC, Lin YL. (2001). Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J Formos Med Assoc 100: 383-8.
34. Liu Q, Shi JR, Yang Y, et al. (2005). Effects on secretory function of rat gonad by Er-Xian Decoction and its disassembled prescriptions. Chin J Chin Mater Med 30:1023-6.
35. Liu ZG, Zhang R, Li C, et al. (2009). The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. J Ethnopharmacol 123:74-81.
36. Lu DN. (2007). Effect of ER-ZHI-WAN on kidney disease. Henan Tradit Chin Med 27:51-2.
37. Ma KC, Zhu TY, Wang FX. (1996). Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Am J Chin Med 24:77-82.
38. Ma LG. (1998). Introduction of the Chinese medicine treatment on bone fracture. Mod J Integr Chin Tradit West Med 7:74-5.
39. Mathey J, Puel C, Kati-Coulibaly S, et al. (2004). Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat. Calcif Tissue Int 75:169-79.
40. Matsuyama J, Ohnishi I, Kageyama T, et al. (2005). Osteogenesis and angiogenesis in regenerating bone during transverse distraction: Quantitative evaluation using a canine model. Clin Orthop 433: 243-50.
41. Mogi M, Kinpara K, Kondo A. (1999). Involvement of nitric oxide and biopterin in proinflammatory cytokineinduced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1. Biochem Pharmacol 58: 649-54.
42. Mok SK, Chen WF, Lai WP, et al. (2010). Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptordependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159:939-49.
43. Nian H, Qin LP, Zhang QY, et al. (2006). Antiosteoporotic activity of Er- Xian Decoction, a traditional Chinese herbal formula in ovariectomized rats. J Ethnopharmacol 108:96-102.
44. Nicholson NC, Ramp WK, Kneisl JS. (1998). Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro. Clin Orthop Relat Res 347:250-60.
45. Peng LH, Ko CH, Siu SW, et al. (2010). In vitro and in vivo assessment of an herbal formula used topically for bone fracture treatment. J Ethnopharmacol 131:282-9.
46. Qin L, Zhang G, Hung WY, et al. (2005). Phytoestrogen-rich herb formula 'XLGB' prevents OVX-induced deterionration of musculoskeletal tissues at the hip in old rats. J Bone Min Metabol 23:55-61.
47. Qin LP, Han T, Zhang QY, et al. (2008). Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118:271-9.
48. Qiu J. (2007). Traditional medicine: A culture in the balance. Nature 448:126-8.
49. Renno AC, de Moura FM, Dos SN, et al. (2006). Effects of 830-nm laser, used in two doses, on biomechanical properties of osteopenic rat femora. Photomed Laser Surg 24:202-6.
50. Shen XH, Fang ZQ, Wu DX. (1995). Effect of Er-Xian Decoction and its disassembled prescription on enzyme activity and their gene expression of antioxidant enzymes in aging rat. J Integr Chin Tradit West Med 15:672-4.
51. State Food and Drug Administration of China. (2002). National Standards Assembly of Chinese Patent Medicine. Standard No. WS-10269 (ZD-0269)-2002.
52. Sterner-Kock A, Braun RK, Van der Vliet A, et al. (1999). Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J Leukoc Biol 65:834-40.
53. Sun JS, Lin CY, Dong GC, et al. (2002). The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activities. Biomaterials 23:377-85.
54. Suzuki H, Hayakawa M, Kobayashi K. (1997). H2O2-derived free radicals treated fibronectin substratum reduces the bone nodule formation of rat calvarial osteoblast. Mech Ageing Dev 98:113-25.
55. Sze SC, Tong Y, Zhang YB, et al. (2009). A novel mechanism: Erxian Decoction, a Chinese medicine formula, for relieving menopausal syndrome. J Ethnopharmacol 123:27-33.
56. Wang BL, Quan JX, Guo SY, et al. (2000). Effects of Epimedium on the expression of interleukin-6 mRNA in bone of OVX rat. Clin Obstet Gynecol 35:724-6.
57. Wang CH, Zhang ZH, Ma J. (1998). Treatment of 50 cases of osteoporosis with Er-Xian Decoction. Shan Xi Zhong Yi 19:205.
58. Wang JQ, Hu YG, Zheng HJ, Qi ZH. (2002). The effect of icariin on proliferation and differentiation of osteoblasts in vitro. Chin J Clin Rehabil 6:1037-8.
59. Wang S, Hu Y, Tan W, et al. (2012). Compatibility art of traditional Chinese medicine: From the perspective of herb pairs. J Ethnopharmacol 143:412-23.
60. Wang T, Zeng Y, Xu M, Xie JH. (2003). Studies on quality control of Gushuling capsule. Trad Chin Drug Res Clin Pharmacol 14:403-5.
61. Wei M, Yang Z, Li P, et al. (2007). Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35: 663-7.
62. Will R, Palmer R, Bhalla AK. (1989). Osteoporosis in early ankylosing spondylitis: A primary pathological event. Lancet 334:1483-5.
63. Wong MS, Zhang Y. (2013). Flavonoids of Herba epimedii and bone metabolism in experimental ovarian deficiency. In: Preedy VR, ed. Nutrition and Diet in Menopause. London: Springer, 427-40.
64. Wu JB, Fong YC, Tsai HY, et al. (2008). Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588:333-41.
65. Yi YD, Chang IM. (2004). An overview of traditional Chinese herbal formulae and a proposal of a new code system for expressing the formula titles. Evid-based Compl Alt Med 1:125-32.
66. Yokozawa T, Wang TS, Chen CP, Hattori M. (1999). Tinospora tuberculata suppresses nitric oxide synthesis in mouse macrophages. Biol Pharm Bull 22:1306-9.
67. Yue N, Zhi DG, Zhao YG, Su Y. (2009). Pharmacodynamics of Gukangning granular on osteoporosis. Drugs Clinic 24:227-31.
68. Zhang H, Xing WW, Li YS, et al. (2008a). Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas 61:334-9.
69. Zhang JM, Li WL. (2012). Advances in studies on phytoestrogens in the prevention and treatment of postmenopausal osteoporosis. Drugs Clinic 27:65-9.
70. Zhang P, Dai K, Yan SG, et al. (2009a). Effects of naringin on the proliferation and osteogenic, differentiation of human bone mesenchymal stem cell. Eur J Pharmacol 607:1-5.
71. Zhang R, Liu ZG, Li C, et al. (2009b). Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 45:553-9.
72. Zhang XZ, Han JF, Qian GF, et al. (2004). Effects of Xianling Gubao capsule on bone mineral density and cytokines in postmenopausal osteaporofic patients. Chin J Osteoporosis 10:90-3.
73. Zhang Y, Dong XL, Leung PC, et al. (2008b). Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558-65.
74. Zhang Y, Leung PC, Che CT, et al. (2008c). Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Brit J Nutr 99:494-502.
75. Zhang Y, Li Q, Li X, et al. (2010). Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Brit J Nutr 104:965-71.
76. Zhang Y, Li X, Lai WP, et al. (2007). Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. J Ethnopharmacol 109: 165-9.
77. Zhao XL, Feng YX, Peng Y. (2012). Prevention and treatment of osteoporosis with Chinese herbal medicines. Chin Herbal Med 4: 265-70.
78. Zhu HM, Qin L, Garnero P, et al. (2012). The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporos Int 23:1317-27.